DexCom Inc (NAS:DXCM)
$ 80.47 1.06 (1.33%) Market Cap: 31.02 Bil Enterprise Value: 30.73 Bil PE Ratio: 47.55 PB Ratio: 15.66 GF Score: 81/100

Dexcom Inc at Piper Sandler Ophthalmology and Diabetes Symposium (Virtual) Transcript

May 25, 2022 / 05:00PM GMT
Release Date Price: $70.33 (-2.36%)
Matthew Oliver O;Brien
Piper Sandler & Co., Research Division - MD & Senior Research Analyst

' -

Good afternoon, everybody. It's Matt O'Brien from Piper's MedTech research team on here with you. Thanks for joining our Annual Diabetes Day conference. We're really excited to have DexCom on with us. From the company is Brice Bobzien, the Senior Vice President of Finance. I think Sean and Matt are kind of in the background as well, listening in.

Format of the call is going to be pretty typical. A bunch of questions from me. This is an interactive session, so please do use the Q&A feature at the bottom of the Zoom, if you have questions, or just e-mail me, and I'm happy to ask those questions on your behalf. It's [email protected].

And with those comments out of the way, let's go ahead and get started. Brice, thanks again for the time here today. Really appreciate you hopping on with us.

Brice Bobzien
DexCom, Inc. - VP of Finance

Of course, Matt, thanks so much for having us. I appreciate the opportunity.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot